BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1852 related articles for article (PubMed ID: 15268862)

  • 1. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.
    Sarbassov DD; Ali SM; Kim DH; Guertin DA; Latek RR; Erdjument-Bromage H; Tempst P; Sabatini DM
    Curr Biol; 2004 Jul; 14(14):1296-302. PubMed ID: 15268862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes.
    Kudchodkar SB; Yu Y; Maguire TG; Alwine JC
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14182-7. PubMed ID: 16959881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.
    Kim DH; Sarbassov DD; Ali SM; Latek RR; Guntur KV; Erdjument-Bromage H; Tempst P; Sabatini DM
    Mol Cell; 2003 Apr; 11(4):895-904. PubMed ID: 12718876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin regulates the phosphorylation of rictor.
    Akcakanat A; Singh G; Hung MC; Meric-Bernstam F
    Biochem Biophys Res Commun; 2007 Oct; 362(2):330-3. PubMed ID: 17707343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
    Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
    J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
    J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of rictor as a novel substrate of Polo-like kinase 1.
    Shao T; Liu X
    Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raptor and mTOR: subunits of a nutrient-sensitive complex.
    Kim DH; Sabatini DM
    Curr Top Microbiol Immunol; 2004; 279():259-70. PubMed ID: 14560962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raptor, a binding partner of target of rapamycin.
    Yonezawa K; Tokunaga C; Oshiro N; Yoshino K
    Biochem Biophys Res Commun; 2004 Jan; 313(2):437-41. PubMed ID: 14684181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.
    Kim DH; Sarbassov DD; Ali SM; King JE; Latek RR; Erdjument-Bromage H; Tempst P; Sabatini DM
    Cell; 2002 Jul; 110(2):163-75. PubMed ID: 12150925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.
    Hara K; Maruki Y; Long X; Yoshino K; Oshiro N; Hidayat S; Tokunaga C; Avruch J; Yonezawa K
    Cell; 2002 Jul; 110(2):177-89. PubMed ID: 12150926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation.
    Wang X; Yue P; Kim YA; Fu H; Khuri FR; Sun SY
    Cancer Res; 2008 Sep; 68(18):7409-18. PubMed ID: 18794129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IKK interacts with rictor and regulates mTORC2.
    Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
    Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation.
    Delgoffe GM; Kole TP; Cotter RJ; Powell JD
    Mol Immunol; 2009 Aug; 46(13):2694-8. PubMed ID: 19586661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells.
    Fuhler GM; Tyl MR; Olthof SG; Lyndsay Drayer A; Blom N; Vellenga E
    Eur J Haematol; 2009 Sep; 83(3):235-45. PubMed ID: 19341427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.
    Oshiro N; Yoshino K; Hidayat S; Tokunaga C; Hara K; Eguchi S; Avruch J; Yonezawa K
    Genes Cells; 2004 Apr; 9(4):359-66. PubMed ID: 15066126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.
    Wang S; Amato KR; Song W; Youngblood V; Lee K; Boothby M; Brantley-Sieders DM; Chen J
    Mol Cell Biol; 2015 Apr; 35(7):1299-313. PubMed ID: 25582201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins.
    Liu L; Chen L; Chung J; Huang S
    Oncogene; 2008 Aug; 27(37):4998-5010. PubMed ID: 18504440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian target of rapamycin and Rictor control neutrophil chemotaxis by regulating Rac/Cdc42 activity and the actin cytoskeleton.
    He Y; Li D; Cook SL; Yoon MS; Kapoor A; Rao CV; Kenis PJ; Chen J; Wang F
    Mol Biol Cell; 2013 Nov; 24(21):3369-80. PubMed ID: 24006489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 93.